Shandong Boan Biotechnology Co., Ltd. (FRA:UJ9)
Germany · Delayed Price · Currency is EUR 0.8800
+0.0100 (1.15%)
Last updated: Jan 28, 2026, 3:25 PM CET
FRA:UJ9 Revenue
Shandong Boan Biotechnology had revenue of 393.41M CNY in the half year ending June 30, 2025, with 50.60% growth. This brings the company's revenue in the last twelve months to 756.78M, up 5.13% year-over-year. In the year 2024, Shandong Boan Biotechnology had annual revenue of 726.32M with 17.50% growth.
Revenue (ttm)
756.78M CNY
Revenue Growth
+5.13%
P/S Ratio
6.21
Revenue / Employee
1.06M CNY
Employees
714
Market Cap
558.71M EUR
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 726.32M | 108.19M | 17.50% |
| Dec 31, 2023 | 618.13M | 102.17M | 19.80% |
| Dec 31, 2022 | 515.96M | 357.26M | 225.11% |
| Dec 31, 2021 | 158.70M | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Paul Hartmann AG | 2.44B |
| FRoSTA Aktiengesellschaft | 652.00M |
| Maschinenfabrik Berthold Hermle AG | 469.42M |
| Südwestdeutsche Salzwerke AG | 347.96M |
| EUROKAI GmbH & Co. KGaA | 262.47M |
| Northern Data AG | 200.27M |
| Berliner Effektengesellschaft AG | 174.56M |
| Novabase S.G.P.S. | 130.35M |